Cardiovascular Medicine Research

The research and academic aspects of our clinical programs are being developed in close connection and alignment to the development of their clinical/patient care aspects. This parallel development is mutually beneficial both to the research potential and the clinical/patient care potential. One feeds positively to the other in a full circle configuration.

We have a long history of building clinical programs of excellence to better treat our own patients and at the same time advance a whole clinical field bringing benefits to patients beyond the boundaries of our institution and state. Some of those include: 

• Long QT Legend: Revolutionized Arrhythmia World and Pharma World
• Defined Role of EP Studies and EKG Holter in Arrhythmias
• Beta-Blocker 'Revolution' in HF
• Defined Myocarditis Diagnosis & Therapy
• Gene Discoveries: Cardiomyopathies, HHT, Supravalvular Stenosis and many others
• Pioneering Mechanical Circulatory Support: IABP Development ('60s–'70s) + First Total Artificial Heart ('60s–'80s - Read More), + Continued Driver of Innovation in the field.
• U.T.A.H. Cardiac Transplant Program: Driving Innovation since 1985 +  one of handful programs worldwide > 1500 transplants
• Antibody Mediated Rejection (AMR) Legend in Heart Transplantation